Confidor, consisting of two major components - imidacloprid and the solvent N-methyl pyrrolidone is a relatively new class of insecticide. Reports of acute overdose or adverse effects after human exposure have been few, despite wide usage. We report a case of acute confidor intoxication with mimicking cholinergic syndrome, the patient ultimately dying of nosocominal pneumonia. Patients ingesting large volumes of imidacloprid-N-methyl pyrrolidone insecticide formulations require close observation and supportive treatment.
Akesson, B. and Paulsson, K.1997: Experimental exposure of male volunteers to N-methyl-2-pyrrolidone (NMP): acute effects and pharmacokinetics of NMP in plasma and urine. Journal of Occupational and Environmental Medicine54 (4), 236-240.
2.
Chao, S. L. and Casida, J. E.1997: Interaction of imidacloprid metabolites and analogs with the nicotinic acetylcholine receptor of mouse brain in relation to toxicity. Archives of Insect Biochemistry and Physiology58, 77-88.
3.
Felsot, A.2001: Admiring risk reduction. Does imidacloprid have what it takes? Agricultural and Environmental News186, 1-13.
4.
Leira, H. L., Tiltness, A. and Svendsen, K.1992: Irritant cutaneous reactions to N-methyl-2-pyrrolidone (NMP). Contact Dermatitis27(3), 148-150.
5.
Moreau, J. P., Vachon, P. J. and Huneau, M. C.2001: Elevated glycemia and local inflammation after injecting N -methyl-2-pyrrolidone (NMP) into the marginal ear vein of rabbits. Contemporary Topics in Laboratory Animal Science40(1), 38-40.
Sheets, L. P.2001: Imidacloprid: a neonicotinoid insecticide. In Krieger, R. I., editor, Handbook of pesticide toxicology, Volume 2, second edition, New York, NY: Academic Press, 1-8.
8.
Tonder, J. E. and Olesen P. H.2001: Agonists at the a4b2 nicotinic acetylcholine receptors: structure -activity relationships and molecular modelling. Current Medicinal Chemistry8, 651-674.
9.
Wu, I. W., Lin, J. L. and Cheng, E. T.2001: Acute poisoning with the neonicotinoid insecticide imidacloprid in N -methyl pyrrolidone. Journal of Toxicology Clinical Toxicology39, 617-621.
